DNAL1 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to provide a robust loss-of-function model for investigating the role of DNAL1 in ciliary biology. The product is derived from the HeLa cell line through targeted disruption of the DNAL1 gene using CRISPR/Cas9 technology, generating a heterogeneous pool of cells with diverse knockout alleles. This polyclonal format captures a wide range of genetic perturbations, offering a physiologically relevant system for studying gene-dosage effects and population-level phenotypes without the clonal bias inherent in single-cell-derived lines. The model is particularly suited for high-content screening and studies requiring statistical power from mixed genotypes.
HeLa cells are an immortal epithelial cell line originally derived from a human cervical adenocarcinoma, and they serve as a versatile host for gene-editing applications. These cells are widely employed in biomedical research due to their robust growth characteristics, ease of transfection, and capacity to undergo ciliogenesis under defined culture conditions. While not a classical ciliated model, HeLa cells can be induced to form primary cilia and express a range of ciliary components, making them a tractable system for dissecting the molecular machinery of axonemal assembly and motility. The epithelial origin also provides contextual relevance for studies of mucociliary clearance and epithelial barrier function.
DNAL1 encodes a light chain component of the outer dynein arm complex, a key structure that generates force for ciliary and flagellar beating. DNAL1 expression is transcriptionally regulated by master ciliogenic factors such as FOXJ1 and the RFX family members RFX2 and RFX3, which orchestrate the program of ciliated cell differentiation. The DNAL1 protein interacts directly with other dynein arm constituents including the heavy chain DNAH5 and intermediate chain DNAI1, as well as with microtubule-associated proteins like tubulin and tektins, to form functional axonemal dynein motors. Disruption of DNAL1 impairs outer dynein arm assembly and stability, leading to reduced ciliary beat frequency, defective mucociliary clearance, and aberrant left-right axis determination. These molecular relationships position DNAL1 as a critical node in the ciliary motility pathway.
In the HeLa background, this DNAL1 knockout model enables precise interrogation of dynein-dependent ciliary functions in an epithelial context. The loss of DNAL1 is expected to phenocopy aspects of primary ciliary dyskinesia (PCD), a disorder characterized by chronic respiratory infections, situs inversus, and male infertility due to immotile cilia and flagella. By coupling the knockout cells with appropriate induction protocols, researchers can assess ciliary ultrastructure, beat frequency, and signaling outputs, thereby linking genomic perturbation to functional outcomes. The model is also well-suited for chemical or genetic modifier screens aimed at restoring ciliary motility.
Typical research applications include immunofluorescence staining for ciliary markers such as acetylated tubulin to visualize axonemal integrity, high-speed video microscopy to quantify ciliary beat frequency, and western blot analysis of dynein components to assess outer arm assembly. RT-qPCR can be used to profile changes in ciliogenesis genes, while flow cytometry enables quantification of ciliated cell populations. These assays support studies of dynein assembly dynamics, ciliary signal transduction, and disease modeling. For further technical details and custom service inquiries, please contact Ascent Research.
